Exposure of human peripheral blood mononuclear cells (PBMC) to hydrostatic pressure increases their proliferative response to phytohemagglutinin A (PHA) and anti-CD3 antibody. 1999

A Eisenthal, and A Gelfand, and F Misonzhnik, and L Trejo, and I Schwartz, and Y Skornick, and B Lifschitz-Mercer
Pathology Institute, Tel-Aviv Sourasky Medical Center, Israel.

In the present study we show that a brief exposure of human PBMC to hydrostatic pressure (HyP) increased their proliferative response to PHA and anti-CD3 antibody, assessed by DNA synthesis. The effect of HyP was most prominent at 400 atmospheres of HyP followed by 600 and 200 atmospheres. At any pressure level, the highest effect of HyP was noted when employing PHA and anti-CD3 antibody at 10(-2) dilution. When PBMC were exposed to 400 atmospheres HyP, maximal effect was achieved at 20 minutes of exposure. The highest effect of HyP on DNA synthesis was noted at 48 and 72 hours of incubation with PHA, when exposing cells to pressure for 20 minutes at 400 atmospheres. Exposure of PBMC under similar conditions for 40 minutes, caused an increase in DNA synthesis only at 48 hours incubation with PHA. These results demonstrate that exposure of human PBMC to HyP increases their proliferative response to different polyclonal activators. The possible mechanisms involved in this phenomenon are discussed.

UI MeSH Term Description Entries
D007963 Leukocytes, Mononuclear Mature LYMPHOCYTES and MONOCYTES transported by the blood to the body's extravascular space. They are morphologically distinguishable from mature granulocytic leukocytes by their large, non-lobed nuclei and lack of coarse, heavily stained cytoplasmic granules. Mononuclear Leukocyte,Mononuclear Leukocytes,PBMC Peripheral Blood Mononuclear Cells,Peripheral Blood Human Mononuclear Cells,Peripheral Blood Mononuclear Cell,Peripheral Blood Mononuclear Cells,Leukocyte, Mononuclear
D008213 Lymphocyte Activation Morphologic alteration of small B LYMPHOCYTES or T LYMPHOCYTES in culture into large blast-like cells able to synthesize DNA and RNA and to divide mitotically. It is induced by INTERLEUKINS; MITOGENS such as PHYTOHEMAGGLUTININS, and by specific ANTIGENS. It may also occur in vivo as in GRAFT REJECTION. Blast Transformation,Blastogenesis,Lymphoblast Transformation,Lymphocyte Stimulation,Lymphocyte Transformation,Transformation, Blast,Transformation, Lymphoblast,Transformation, Lymphocyte,Activation, Lymphocyte,Stimulation, Lymphocyte
D010835 Phytohemagglutinins Mucoproteins isolated from the kidney bean (Phaseolus vulgaris); some of them are mitogenic to lymphocytes, others agglutinate all or certain types of erythrocytes or lymphocytes. They are used mainly in the study of immune mechanisms and in cell culture. Kidney Bean Lectin,Kidney Bean Lectins,Lectins, Kidney Bean,Phaseolus vulgaris Lectin,Phaseolus vulgaris Lectins,Phytohemagglutinin,Hemagglutinins, Plant,Lectin, Kidney Bean,Lectin, Phaseolus vulgaris,Lectins, Phaseolus vulgaris,Plant Hemagglutinins
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006874 Hydrostatic Pressure The pressure due to the weight of fluid. Hydrostatic Pressures,Pressure, Hydrostatic,Pressures, Hydrostatic
D000906 Antibodies Immunoglobulin molecules having a specific amino acid sequence by virtue of which they interact only with the ANTIGEN (or a very similar shape) that induced their synthesis in cells of the lymphoid series (especially PLASMA CELLS).
D017252 CD3 Complex Complex of at least five membrane-bound polypeptides in mature T-lymphocytes that are non-covalently associated with one another and with the T-cell receptor (RECEPTORS, ANTIGEN, T-CELL). The CD3 complex includes the gamma, delta, epsilon, zeta, and eta chains (subunits). When antigen binds to the T-cell receptor, the CD3 complex transduces the activating signals to the cytoplasm of the T-cell. The CD3 gamma and delta chains (subunits) are separate from and not related to the gamma/delta chains of the T-cell receptor (RECEPTORS, ANTIGEN, T-CELL, GAMMA-DELTA). Antigens, CD3,CD3 Antigens,T3 Antigens,CD3 Antigen,T3 Antigen,T3 Complex,Antigen, CD3,Antigen, T3,Antigens, T3

Related Publications

A Eisenthal, and A Gelfand, and F Misonzhnik, and L Trejo, and I Schwartz, and Y Skornick, and B Lifschitz-Mercer
January 1998, Viral immunology,
A Eisenthal, and A Gelfand, and F Misonzhnik, and L Trejo, and I Schwartz, and Y Skornick, and B Lifschitz-Mercer
January 2001, Archivum immunologiae et therapiae experimentalis,
A Eisenthal, and A Gelfand, and F Misonzhnik, and L Trejo, and I Schwartz, and Y Skornick, and B Lifschitz-Mercer
March 2001, Gene therapy,
A Eisenthal, and A Gelfand, and F Misonzhnik, and L Trejo, and I Schwartz, and Y Skornick, and B Lifschitz-Mercer
September 1989, Journal of reproductive immunology,
A Eisenthal, and A Gelfand, and F Misonzhnik, and L Trejo, and I Schwartz, and Y Skornick, and B Lifschitz-Mercer
February 1997, Clinical and experimental immunology,
A Eisenthal, and A Gelfand, and F Misonzhnik, and L Trejo, and I Schwartz, and Y Skornick, and B Lifschitz-Mercer
August 1997, Clinica chimica acta; international journal of clinical chemistry,
A Eisenthal, and A Gelfand, and F Misonzhnik, and L Trejo, and I Schwartz, and Y Skornick, and B Lifschitz-Mercer
January 1995, Microbiology and immunology,
A Eisenthal, and A Gelfand, and F Misonzhnik, and L Trejo, and I Schwartz, and Y Skornick, and B Lifschitz-Mercer
September 2008, Journal of ethnopharmacology,
A Eisenthal, and A Gelfand, and F Misonzhnik, and L Trejo, and I Schwartz, and Y Skornick, and B Lifschitz-Mercer
April 1983, Agents and actions,
A Eisenthal, and A Gelfand, and F Misonzhnik, and L Trejo, and I Schwartz, and Y Skornick, and B Lifschitz-Mercer
January 1999, Methods in molecular medicine,
Copied contents to your clipboard!